| 2006 (Jul-Dec) N (%) | 2007 N (%) | 2008 N (%) | Total N (%) | p** (2007 vs. 2008) |
---|---|---|---|---|---|
Total number of sites | 14 | 19 | 32 | - | - |
   Full package | 5 (35.7%) | 15 (79%) | 18 (56%) | - | - |
Counseling and testing of pregnant women in ANC: | Â | Â | Â | Â | Â |
   First ANC visit | 4,520 | 15,469 | 20,685 | 40,674 | - |
   Known to be HIV positive | NA | 135 (0.9%) | 291 (1.4%) | 426 (1%) | - |
   Tested for HIV | 4,452 (98%) | 15,231 (98%) | 20,564 (99%) | 40,247 (99%) | <0.0001 |
   Tested HIV positive | 234 (5%) | 741 (5%) | 647 (3%) | 1,622 (4%) | <0.0001 |
Partner counseling and HIV testing | NA | 8,652 (57%) | 15,463 (75%) | 24,115 (67%)$ | <0.0001 |
CD4 cell count assessment during pregnancy | Â | Â | Â | Â | Â |
   Total HIV positive in ANC | 234 | 876 | 938 | 2,048 | - |
   Screened for CD4 cell counts¶ | 140 (60%) | 610 (70%) | 658 (70%) | 1,408 (69%) | 0.81 |
   Received CD4 cell count results¶¶ | NA | 564 (92%) | 647 (98%) | 1,211 (96%)$ | <0.0001 |
   CD4 cell counts < 350 cells/mm3 | NA | 132 (23%) | 160 (25%) | 292 (24%)$ | 0.59 |
Enrolment of HIV positive women into care and treatment | NA | 180/443 (41%)@ | 564/938 (60%) | 744/1381 (54%)$ | - |
HAART initiation for women with CD4 cell counts < 350 cells/mm3 | NA | 114/132 (86%) | 127/160 (79%) | 241/292 (83%)$ | 0.12 |
Total HIV positive in ANC | 234 | 876 | 938 | 2,048 | Â |
All ARV regimens initiated during pregnancy | 155 (66%) | 667 (76%) | 638 (68%) | 1460 (71%) | Â |
   Dual (AZT/NVP) prophylaxis | 55 (35.5%) | 386 (58%) | 403 (63%) | 844 (58%) |  |
   HAART for life | NA | 114 (17%) | 127 (20%) | 241 (16%) |  |
   sd-nvp only | 100 (64.5%) | 34 (5%) | 21 (3%) | 155 (11%) |  |
   Short-course HAART | NA | 133 (20%) | 87 (14%) | 220 (15%) |  |
More efficacious ARV regimens (dual ARV, or HAART for life or sc-HAART) | 55 (35.5%) | 633 (95%) | 617 (97%) | 1325 (89%) | Â |